Barba, T. (2018) “Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis: experience from the STAT registry”, Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 34(4), pp. 343–351. doi:10.36141/svdld.v34i4.5817.